Results 11 to 20 of about 62,097 (108)

Adjuvant Radiotherapy in Patients with Squamous Cell Carcinoma of the Oral Cavity or Oropharynx and Solitary Ipsilateral Lymph Node Metastasis (pN1)—A Prospective Multicentric Cohort Study

Cancers, 2023
Simple Summary In brief, this is the first prospective study using a multicentric approach to investigate the effectiveness of adjuvant radiotherapy in patients with early squamous cell carcinoma of the oral cavity (T1/2) and the oropharynx (T1) with one
P. W. Kämmerer, S. Tribius, Lena Cohrs, Gabriel Engler, T. Ettl, K. Freier, B. Frerich, S. Ghanaati, M. Gosau, D. Haim, S. Hartmann, M. Heiland, Manuel Herbst, S. Hoefert, Jürgen Hoffmann, F. Hölzle, H. Howaldt, K. Kreutzer, H. Leonhardt, R. Lutz, M. Moergel, A. Modabber, Andreas Neff, S. Pietzka, A. Rau, T. Reichert, R. Smeets, C. Sproll, D. Steller, J. Wiltfang, K. Wolff, K. Kronfeld, B. Al‐Nawas   +32 more
semanticscholar   +1 more source

Neutrophil-to-lymphocyte ratio predicts nodal involvement in unfavourable, clinically nonmetastatic prostate cancer patients and overall survival in pN1 patients

Scientific Reports, 2023
The aim of our study was to determine the clinical utility of neutrophil-to-lymphocyte ratio (NLR) in predicting presence and prognosis of nodal involvement in patients treated with radical prostatectomy (RP) due to prostate cancer.
Piotr Zapała, K. Garbas, Z. Lewandowski, A. Ślusarczyk, Cezary Ślusarczyk, Łukasz Mielczarek, G. Marra, B. Pradère, P. Rajwa, Łukasz Zapała, P. Radziszewski   +10 more
semanticscholar   +1 more source

Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death

Journal of Clinical Oncology, 2022
PURPOSE An association with a reduction in the risk of all-cause mortality (ACM) and the use of adjuvant as compared with early postradical prostatectomy salvage radiation therapy (sRT) in men with pN1 prostate cancer (PC) has been observed. Yet, whether
D. Tilki, Ming-Hui Chen, Jing Wu, H. Huland, M. Graefen, A. D'Amico   +5 more
semanticscholar   +1 more source

Ultrasound and Contrast-Enhanced Ultrasound Characteristics Associated With cN1 and Microscopic pN1 in Papillary Thyroid Carcinoma

Frontiers in Endocrinology, 2022
Objectives Lymph node metastases (LNMs) could be stratified into clinical N1 (cN1) and microscopic pN1 (pathological N1), which bear different biological behavior and prognosis.
Wen Li, Shusheng Qiu, L. Ren, Qiuyang Li, Shao-wei Xue, Jie Li, Yan Zhang, Yukun Luo   +7 more
semanticscholar   +1 more source

Postoperative radiotherapy to the neck for pN1 status HNSCC patients after neck dissection

Scientific Reports, 2022
The significance of postoperative radiotherapy (PORT) to the neck for pN1 status head and neck squamous cell carcinomas (HNSCC) after neck dissection is unclear.
Jia Wang, X. Su, Xing Zhang, Wen-kuang Chen, Jibin Li, Zhong-yuan Yang, Xiyuan Li, Jingtao Chen, Ying Zhang, Shu-wei Chen, Ming Song   +10 more
semanticscholar   +1 more source

The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study

Diseases of the Colon & Rectum, 2022
BACKGROUND: Lymph node skip metastasis is a subgroup of lymph node metastatic patterns with low incidence in node-positive colon cancer. Its clinical significance is still unclear. OBJECTIVE: This study aimed to investigate the prognostic impact of lymph
Chenglin Chang, Chun-Chi Lin, Hung-Hsin Lin, Y. Lan, Shih-Ching Chang, Huann‐Sheng Wang, Shung-Haur Yang, Wei‐Shone Chen, Jen‐Kou Lin, Jeng-Kai Jiang   +9 more
semanticscholar   +1 more source

Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis

Cancers, 2021
Simple Summary The analysis of prognostic biomarkers (e.g., PD-L1) helps to define treatment for lung cancer patients. To date, these markers have only been examined in metastatic or inoperable situations.
F. Eichhorn, M. Kriegsmann, L. Klotz, K. Kriegsmann, T. Muley, C. Zgorzelski, P. Christopoulos, H. Winter, M. Eichhorn   +8 more
semanticscholar   +1 more source

The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1)

Anticancer Research, 2021
Background/Aim: We compared postoperative radiotherapy (PORT) to surgery only (SO), and supraomohyoidal neck dissection (SOHND) to modified radical neck dissection (MRND) in patients with pT1-T2 squamous cell carcinomas of the oral cavity (OSCC) and a ...
U. Alsharif, D. Steller, M. Falougy, L. Tharun, D. Rades, S. Hakim   +5 more
semanticscholar   +1 more source

The role of postoperative radiotherapy in pN1 oral cavity cancer without extranodal extension

World Journal of Surgical Oncology, 2021
Background The administration of postoperative radiotherapy remains controversial in pN1 oral cavity cancer patients without extranodal extension. The aim is to determine whether postoperative radiotherapy reduces the neck recurrence rate and improves ...
Tsung-You Tsai, Yenlin Huang, A. Iandelli, S. Tai, Shao-Yu Hung, H. Kao, K. Chang   +6 more
semanticscholar   +1 more source

Lymph Node Metastasis Location and Postoperative Adjuvant Chemotherapy in Patients With pN1 Stage IIB Non-small Cell Lung Cancer

In Vivo, 2021
Background/Aim: The benefit of adjuvant chemotherapy for patients with pN1 non–small cell lung cancer (NSCLC) according to the location of lymph node (LN) metastases remains unclear.
Ryuichi Ito, Takuma Tsukioka, N. Izumi, Hiroaki Komatsu, Hidetoshi Inoue, Takuya Kimura, K. Kishimoto, N. Nishiyama   +7 more
semanticscholar   +1 more source